Sinovac Biotech Ltd. (SVA)
NASDAQ: SVA
· Real-Time Price · USD
6.47
0.00 (0.00%)
At close: Feb 11, 2025, 6:18 AM
Sinovac Biotech Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2024 | Q3 2023 | Q1 2023 | Q3 2022 | Q1 2022 | Q3 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 |
Cash & Equivalents | 1.27B | 1.64B | 4.28B | 6.86B | 11.61B | 6.84B | 1.04B |
Short-Term Investments | 9.95B | 9.43B | 7.03B | 4.99B | 1.81B | 2.97B | 135.25M |
Long-Term Investments | 684.28M | 657.77M | 661.44M | 697.12M | 655.84M | 7.11M | n/a |
Other Long-Term Assets | 7.37M | 2.33M | 2.82M | 24K | 25K | -7.08M | 25K |
Receivables | 450.72M | 500.44M | 609.49M | 969.56M | 952.4M | 1.39B | 253.49M |
Inventory | 139.87M | 182.74M | 180.72M | 266.86M | 375.51M | 407.66M | 105.81M |
Other Current Assets | 5.17M | 3.73M | 8.25M | 9.19M | 10.9M | 12.71M | 9.2M |
Total Current Assets | 11.83B | 11.77B | 12.13B | 13.12B | 14.92B | 11.69B | 1.56B |
Property-Plant & Equipment | 1.03B | 1.12B | 1.17B | 1.14B | 1.08B | 776.49M | 304.4M |
Goodwill & Intangibles | 74.06M | 74.27M | 79.51M | 46.25M | 41.21M | 22.29M | 9.72M |
Total Long-Term Assets | 1.83B | 1.96B | 1.99B | 1.95B | 1.83B | 938.8M | 341.03M |
Total Assets | 13.66B | 13.73B | 14.11B | 15.07B | 16.75B | 12.63B | 1.9B |
Account Payables | 17.29M | 819.53M | 19.82M | 334.29M | 58.59M | 958.87M | 30.54M |
Deferred Revenue | 21.71M | 19.29M | 33.08M | 43.97M | 92.5M | 349.26M | 379.16M |
Short-Term Debt | 76.09M | 205.28M | 4.65M | 1.6M | 4.68M | 35.68M | 39.1M |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 1.15B | 1.19B | 1.09B | 564.86M | 2.41B | 3.31B | 679.61M |
Long-Term Debt | 177.82M | 10.99M | 11.51M | 16.63M | 17.38M | 18.75M | 8.29M |
Other Long-Term Liabilities | 439K | 630K | 240K | 137K | 444K | 866K | 865K |
Total Long-Term Liabilities | 481.44M | 298.13M | 310.27M | 407.07M | 459.32M | 189.91M | 101.59M |
Total Liabilities | 1.64B | 1.49B | 1.4B | 971.93M | 2.87B | 3.5B | 781.2M |
Total Debt | 298.98M | 263.19M | 74.67M | 81.72M | 144.91M | 174.58M | 136.39M |
Common Stock | 100K | 100K | 100K | 100K | 100K | 99K | 99K |
Retained Earnings | 7.12B | 7.24B | 7.23B | 7.62B | 7.14B | 5.25B | 144.24M |
Comprehensive Income | 1.05B | 883.55M | 1.15B | 1.3B | 1.64B | 90.03M | 70.3M |
Shareholders Equity | 8.71B | 8.66B | 8.92B | 9.47B | 9.33B | 5.87B | 746.47M |
Total Investments | 10.64B | 10.08B | 7.7B | 5.69B | 2.46B | 2.97B | 135.25M |